58
landing page
Global Market Development
About Global Market Development
Robust capital markets and innovative finance drive prosperity by h
elping ensure that national savings are efficiently allocated to the best private-sector gro
+ Read More
person
Edward McGee
Edward McGee is the interim CEO and chief financial officer of Grayscale Investments, overseeing
daily financial activities and identifying growth opportunities for the company.
+ Read More
staff
Tanisha London, PhD
Tanisha London, PhD, is a senior associate with the Milken Institute Science Philanthropy Acceler
ator for Research and Collaboration (SPARC) team.
+ Read More
staff
Danielle Graham
Danielle Graham is a senior associate at MI Philanthropy working to advance the learning agenda a
nd giving practices of corporate philanthropy leaders and other philanthropic actors.
+ Read More
staff
Taylor Evans, PhD
Taylor Evans, PhD, is a senior associate at the Milken Institute Science Philanthropy Accelerator
for Research and Collaboration (SPARC). Her expertise lies in biomedical research, molecular genetics, rare diseases, and computational biology tools.
+ Read More
staff
Shannon Stroud
Shannon has over 25 years financial services and private capital experience and currently is a Di
rector with Milken Institute’s Center for Global Market Development where she works to inform financial and economic policy across developing and emerging m
+ Read More
staff
Maxwell DeGregorio
Maxwell DeGregorio is an Associate at the Center for Financial Markets at the Milken Institute.
report
Key Trends in Health at Milken Institute Global Conference 2024
The 27th Milken Institute Global Conference delved into the theme “Shaping a Shared Future.” Throug
hout the four-day event, MI Health launched key initiatives and highlighted ongoing
+ Read More
report
Catalyzing Action for Pharmacist-Provided Food Is Medicine Care
Pharmacies are cornerstones of local health care, providing access to immunizations, screenings, tr
eatments, and health-related social needs across communities.
+ Read More
report
Distance as an Obstacle to Clinical Trial Access: Who Is Affected and Why It Matters
Access to clinical trials is valuable for patients as it provides the possibility to obtain novel t
reatments that are not yet commercially available.
+ Read More
article
Medicare Drug Price Negotiation Program Comment Letter
Meena Seshamani, M.D., Ph.D.
Deputy Administrator and Director of the Center for Medicare
Centers fo
r Medicare & Medicaid Services
US Department of Health and Human Services
Baltimore, Maryland 21244
Dear Dr. Seshamani,
+ Read More
article
Tech Regulation Digest: Antitrust Scrutiny: Apple's Evolving Regulatory Strategies
Overview
Apple’s dominance in the US smartphone industry and its competition strategies have faced
mounting scrutiny from regulatory bo
+ Read More